# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-25-000036
Filing Date
2025-05-09
Accepted
2025-05-09 16:04:28
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20250331.htm iXBRL | 10-Q | 1091453
2 | EX-2.1 | exhibit21_ligand-castlecre.htm | EX-2.1 | 638626
3 | EX-31.1 | lgnd_33125exhibit311.htm | EX-31.1 | 15156
4 | EX-31.2 | lgnd_33125exhibit312.htm | EX-31.2 | 15426
5 | EX-32.1 | lgnd_33125exhibit321.htm | EX-32.1 | 11156
11 |  | lgnd-20250331_g1.jpg | GRAPHIC | 43732
| Complete submission text file | 0000886163-25-000036.txt |  | 8842123

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20250331.xsd | EX-101.SCH | 57840
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20250331_cal.xml | EX-101.CAL | 105068
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20250331_def.xml | EX-101.DEF | 331178
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20250331_lab.xml | EX-101.LAB | 819447
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20250331_pre.xml | EX-101.PRE | 559882
78 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20250331_htm.xml | XML | 1070003

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 25930265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)